MarketPeel
Insider Trading Intelligence
KG

Kevin Charles Gorman

NBIX
CHIEF EXECUTIVE OFFICER · NEUROCRINE BIOSCIENCES INC · CIK 0001201096
FILING MIX · LIFETIME40%/60%
BUYS
40
SELLS
60
TOTAL VALUE
$177.83M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
16,626
AVG SELL PX
$94.56
TRADE KIND
SHOWING 100 / 100
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
39 backtested trades · 8 horizons · 10 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kevin Charles Gorman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d39+71.79%-0.43%+0.34%-0.78%-1.43%-0.75
14d39+43.59%+0.53%-0.02%+0.55%+0.05%0.34
30d39+61.54%-3.05%-1.56%-1.49%-0.25%-0.79
60d39+56.41%-2.67%-0.45%-2.22%-1.34%-0.90
90d39+61.54%-2.97%+0.84%-3.81%-4.03%-1.58
180d39+41.03%+3.80%+8.24%-4.44%-11.54%-1.10
1y39(1 pending)+36.84%+3.89%+19.28%-15.39%-12.22%-3.33
2y39(9 pending)+50.00%+10.84%+32.12%-21.27%-22.57%-3.15
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NBIX · 5,248 shares · as of May 27, 2026
0189,095378,191567,286756,381202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 40 buys / 60 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XNCR
XENCOR INC
SALE10b5-1
10b5-1 plan
7,527$12.31$92.7K11,378Jun 15, 2026Jun 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
5,2485,248May 27, 2026May 29, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
205,088$43.24$8.87M756,381May 19, 2026May 21, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
245,088$154.33$37.82M511,293May 19, 2026May 21, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
205,0880May 19, 2026May 21, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
5,3775,377Feb 13, 2026Feb 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
3,024$124.12$375.3K519,473Feb 13, 2026Feb 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
2,901$124.12$360.1K521,949Feb 13, 2026Feb 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
5,60411,208Feb 13, 2026Feb 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
34,380$124.12$4.27M551,293Feb 13, 2026Feb 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
5,604522,497Feb 13, 2026Feb 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
5,377524,850Feb 13, 2026Feb 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
63,724585,673Feb 13, 2026Feb 17, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
5,142519,738Jan 31, 2026Feb 3, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
2,845$136.06$387.1K516,893Jan 31, 2026Feb 3, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
5,1420Jan 31, 2026Feb 3, 2026View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
106,322$126.41$13.44M514,596Aug 7, 2025Aug 11, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
106,3220Aug 7, 2025Aug 11, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
106,322$35.99$3.83M620,918Aug 7, 2025Aug 11, 2025View →
XNCR
XENCOR INC
SALE10b5-1
10b5-1 plan
3,173$9.22$29.3K18,905Jun 16, 2025Jun 16, 2025View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
13,68622,078Jun 12, 2025Jun 16, 2025View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
27,37227,372Jun 12, 2025Jun 16, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
9,613$120.38$1.16M514,596May 27, 2025May 29, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
6,6106,610May 21, 2025May 22, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
5,603527,221Feb 13, 2025Feb 14, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
3,012$116.68$351.4K524,209Feb 13, 2025Feb 14, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
5,376524,450Feb 13, 2025Feb 14, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
5,37610,754Feb 13, 2025Feb 14, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
5,60316,812Feb 13, 2025Feb 14, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
2,832$116.69$330.5K521,618Feb 13, 2025Feb 14, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
2,274$118.37$269.2K519,074Feb 10, 2025Feb 12, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
4,3180Feb 8, 2025Feb 12, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
4,318521,348Feb 8, 2025Feb 12, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
5,1415,142Jan 31, 2025Feb 4, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
5,141519,737Jan 31, 2025Feb 4, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
2,707$152.92$414.0K517,030Jan 31, 2025Feb 4, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
146,105$32.99$4.82M660,701Jan 27, 2025Jan 29, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
146,105$149.46$21.84M514,596Jan 27, 2025Jan 29, 2025View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
146,1050Jan 27, 2025Jan 29, 2025View →
XNCR
XENCOR INC
SALE
2,654$20.68$54.9K8,392Sep 27, 2024Oct 1, 2024View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
5,98611,046Jun 13, 2024Jun 17, 2024View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
11,97111,971Jun 13, 2024Jun 17, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,778$35.99$100.0K0Feb 13, 2024Feb 14, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
Chief Executive Officer
2,312$43.24$100.0K512,052Feb 13, 2024Feb 14, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,312$43.24$100.0K0Feb 13, 2024Feb 14, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
Chief Executive Officer
2,778$35.99$100.0K509,740Feb 13, 2024Feb 14, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
22,41522,415Feb 13, 2024Feb 15, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
2,832$133.02$376.7K514,596Feb 13, 2024Feb 15, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
112,644112,644Feb 13, 2024Feb 15, 2024View →
XNCR
XENCOR INC
PURCHASE
53$19.12$1.0K5,060Feb 13, 2024Feb 14, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
2,274$134.15$305.1K506,962Feb 8, 2024Feb 8, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
3,040$142.18$432.2K504,919Feb 6, 2024Feb 8, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
2,707$140.69$380.8K502,188Jan 31, 2024Feb 2, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
62,023$19.59$1.22M0Jan 9, 2024Jan 10, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
62,023$134.01$8.31M499,754Jan 9, 2024Jan 10, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
Chief Executive Officer
62,023$19.59$1.22M561,777Jan 9, 2024Jan 10, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
105,835$132.44$14.02M499,754Jan 8, 2024Jan 10, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
Chief Executive Officer
105,835$19.59$2.07M605,589Jan 8, 2024Jan 10, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
105,835$19.59$2.07M62,023Jan 8, 2024Jan 10, 2024View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
9,328$107.40$1.00M499,754Aug 21, 2023Aug 23, 2023View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
10,01310,013Jun 20, 2023Jun 21, 2023View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
5,0075,007Jun 20, 2023Jun 21, 2023View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
133,656133,656Feb 13, 2023Feb 15, 2023View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
21,50621,506Feb 13, 2023Feb 15, 2023View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,274$104.30$237.2K491,365Feb 8, 2023Feb 8, 2023View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,248$102.30$332.3K470,930Feb 7, 2023Feb 8, 2023View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
20,482$102.43$2.10M489,322Feb 7, 2023Feb 8, 2023View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,040$105.68$321.3K468,008Feb 6, 2023Feb 8, 2023View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,707$110.08$298.0K465,278Jan 31, 2023Feb 2, 2023View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
21,41221,412Jun 23, 2022Jun 27, 2022View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,274$79.49$180.8K462,844Feb 8, 2022Feb 9, 2022View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,248$80.82$262.5K458,071Feb 7, 2022Feb 9, 2022View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,040$80.80$245.6K460,801Feb 7, 2022Feb 9, 2022View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,422$80.83$195.8K455,150Feb 7, 2022Feb 9, 2022View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
140,049140,049Jan 31, 2022Feb 2, 2022View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
20,56520,565Jan 31, 2022Feb 2, 2022View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
9,7289,728Jun 24, 2021Jun 25, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,875$116.79$335.8K446,144Feb 8, 2021Feb 9, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
4,343$116.74$507.0K450,051Feb 8, 2021Feb 9, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,248$116.71$379.1K452,972Feb 8, 2021Feb 9, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
103,609103,609Feb 8, 2021Feb 9, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
17,26917,269Feb 8, 2021Feb 9, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
113,863113,863Feb 8, 2021Mar 26, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,422$114.16$276.5K443,249Feb 5, 2021Feb 9, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
143,449$8.66$1.24M0Jan 8, 2021Jan 12, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
164,801$110.22$18.16M441,071Jan 8, 2021Jan 12, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
164,801$8.65$1.43M0Jan 8, 2021Jan 12, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
Chief Executive Officer
143,449$8.66$1.24M584,520Jan 8, 2021Jan 12, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
Chief Executive Officer
164,801$8.65$1.43M605,872Jan 8, 2021Jan 12, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
143,449$110.21$15.81M441,071Jan 8, 2021Jan 12, 2021View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,390$90.78$307.7K441,071Nov 12, 2020Nov 16, 2020View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,390$118.91$403.1K438,021Aug 5, 2020Aug 7, 2020View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
13,95313,953Jun 25, 2020Jun 26, 2020View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,906$99.45$289.0K434,971Apr 24, 2020Apr 28, 2020View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,248$103.35$335.7K432,357Feb 7, 2020Feb 11, 2020View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
4,343$101.56$441.1K429,436Feb 6, 2020Feb 7, 2020View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
145,698145,698Feb 6, 2020Feb 7, 2020View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
23,08123,081Feb 6, 2020Feb 7, 2020View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
2,422$103.09$249.7K425,529Feb 5, 2020Feb 7, 2020View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
Chief Executive Officer
3,027$103.08$312.0K423,351Feb 5, 2020Feb 7, 2020View →
Other insiders · NBIX
Loading peer insiders…
About this filer
CIK 0001201096
ROLE
Chief Executive Officer
PRIMARY
NBIX
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001201096DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback